{"disease":{"id":"sclerosis-multiple","name":"sclerosis multiple"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT06705608","title":"Examining the Risk of Skin Cancer in Multiple Sclerosis Patients Using Fingolimod: a Population-Based Study","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06583395","title":"Quest to Analyze One Thousand Humans Meditating","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3000,"lead_sponsor_name":"Tobias Moeller-Bertram","has_results":false},{"nct_id":"NCT06372145","title":"A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04756687","title":"Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera","phase":"","overall_status":"COMPLETED","enrollment_count":1507,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT01797965","title":"Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1501,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT03900221","title":"French Registry for Monitoring Pregnancies for Multiple Sclerosis","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT01930708","title":"A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1114,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT05204459","title":"MS-ResearchBiomarkerS","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT05426980","title":"Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study","phase":"","overall_status":"COMPLETED","enrollment_count":654,"lead_sponsor_name":"University of Ljubljana","has_results":false},{"nct_id":"NCT04688788","title":"Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03999034","title":"XO as a Screening Test of Cognitive Impairment in Multiple Sclerosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT06433752","title":"A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"TG Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04655222","title":"Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program","phase":"","overall_status":"COMPLETED","enrollment_count":470,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07467187","title":"Invasive Home Ventilation in Denmark","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05758831","title":"RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":386,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04940065","title":"Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen","phase":"","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06526000","title":"Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies","phase":"","overall_status":"COMPLETED","enrollment_count":326,"lead_sponsor_name":"Novartis","has_results":false},{"nct_id":"NCT07222618","title":"\"Selfie\" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05740722","title":"Nicotinamide Riboside Supplementation In Progressive Multiple Sclerosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT04121403","title":"Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"Oslo University Hospital","has_results":false},{"nct_id":"NCT05000216","title":"COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":258,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06320444","title":"Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"University of Dublin, Trinity College","has_results":false},{"nct_id":"NCT05232825","title":"A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT01838668","title":"An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT02525874","title":"Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT04695080","title":"ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":204,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT02057159","title":"A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Immune Response BioPharma, Inc.","has_results":false},{"nct_id":"NCT06112639","title":"The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Fondazione Don Carlo Gnocchi Onlus","has_results":false},{"nct_id":"NCT05961644","title":"Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":188,"lead_sponsor_name":"Institute of Psychiatry and Neurology, Warsaw","has_results":false},{"nct_id":"NCT03623243","title":"Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07235644","title":"Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":184,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT05374811","title":"The Relationship of Neuropathic Pain With Incontinence, Disability and Life Quality in Multiple Sclerosis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT05029206","title":"Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden","phase":"","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT03610139","title":"Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":162,"lead_sponsor_name":"American University of Beirut Medical Center","has_results":false},{"nct_id":"NCT05663853","title":"An Observational Biomarker Study in Multiple Sclerosis (MS) Patients","phase":"","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"LAPIX Therapeutics Inc.","has_results":false},{"nct_id":"NCT03283826","title":"Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":134,"lead_sponsor_name":"Atara Biotherapeutics","has_results":false},{"nct_id":"NCT04260711","title":"Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).","phase":"NA","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT05706220","title":"Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA","has_results":false},{"nct_id":"NCT03872583","title":"Understanding Magnetic Resonance Imaging in Multiple Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT05893225","title":"Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT06395909","title":"A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis","phase":"","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"Novartis","has_results":false},{"nct_id":"NCT06782724","title":"Psilocybin Therapy for Psychological Distress in Palliative Patients","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":108,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT02988401","title":"Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT07492667","title":"Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT05327322","title":"Functional Outcomes From Diets in Multiple Sclerosis","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":false},{"nct_id":"NCT07025122","title":"Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"University Hospital, Martin","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}